Watch leading spinal muscular atrophy (SMA) experts discuss current trends in pharmacologic and non-pharmacologic therapy use, barriers to use of these standards of care, and potential solutions to improve access as patients age.
Watch leading experts discuss the importance of genetic counseling and testing in SMA and ALS.
This touchSERIES is sponsored by Biogen.
Biogen provided financial support and video content, and has had input into the detailed scope for each activity. This touchSERIES is provided by Touch Medical Communications (TMC) for touchNEUROLOGY.
Unapproved products or unapproved uses of approved products may be discussed; these situations may reflect the approval status in one or more jurisdictions. TMC has advised the sponsor to ensure that they disclose any such references made to unlabelled or unapproved use. No endorsement by TMC of any unapproved products or unapproved uses is either made or implied by mention of these products or uses in TMC activities. TMC accepts no responsibility for errors or omissions.
The views and opinions expressed are those of the faculty and do not necessarily reflect those of any sponsor.
Biogen-265493
Date of preparation: May 2025
Login
Sign Up FREE
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register now for FREE Access
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.